Annual report pursuant to Section 13 and 15(d)

Stockholders??? Equity (Deficit) (Details) - Schedule of Total Operating Expenses in the Consolidated Statements of Operations

v3.24.3
Stockholders’ Equity (Deficit) (Details) - Schedule of Total Operating Expenses in the Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Schedule of Compensation Expense Related to Our Stock-Based Awards [Line Items]    
Total Compensation expense $ 2,848 $ 9,407
Research and Development [Member]    
Schedule of Compensation Expense Related to Our Stock-Based Awards [Line Items]    
Total Compensation expense 1,976 3,692
General and Administrative [Member]    
Schedule of Compensation Expense Related to Our Stock-Based Awards [Line Items]    
Total Compensation expense 677 5,715
Cost of Revenue [Member]    
Schedule of Compensation Expense Related to Our Stock-Based Awards [Line Items]    
Total Compensation expense $ 195